Point of Care Molecular Diagnostics Market worth $4.1 billion by 2026


The global point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2% during the forecast period. Growth in the point-of-care molecular diagnostics industry is mainly driven by factors such as the increasing prevalence of infectious diseases and cancer, rising focus on decentralized diagnostics and increasing R&D funding, increasing awareness on the early detection of infectious diseases, and the increasing use of POC diagnostic tests.

comments (0)

31 more from Healthcare_medical